# Refactoring log

This is an append-only record of meaningful work sessions. Add new entries immediately below this introduction, newest first. Use [templates/log-entry.md](./templates/log-entry.md) for the entry format.

## 2026-08-26 — Customer-facing copy refresh validated locally

- **Phase:** 02 — Cream launch monitoring / 04 — Redesign editorial follow-up
- **Status:** Implemented and validated locally; not deployed
- **Summary:** Applied owner-approved customer-facing wording to the homepage, listings, cream content, About, Contacts, and forms; displayed existing product summaries beneath product titles. Removed internal process language and clarified the consultation request without inventing product or service details.
- **Evidence:** [Scope, deferrals, and validation](./phase-04-redesign/artifacts/copy-refresh-2026-08-26.md); 60 passing tests; lint and isolated production build; 12-route rendered validation; desktop/mobile browser and empty-form checks; unchanged product contract comparison.
- **Decisions:** Preserve URLs, H1s, metadata, analytics, product facts, compositions, application instructions, and precautions. Leave the red-pepper ingredient discrepancy, serum usage details, unverified product differences, and consultation specifics for confirmation.
- **Blockers:** No local implementation blocker. Deferred factual questions remain open; no production release was authorized or performed.
- **Next:** Owner reviews the local copy. If separately authorized for release, record the actual deployment date and distinguish pre-/post-copy monitoring observations; retain the existing September 7 operational review date.

## 2026-08-24 — Phase 04 deployed and Phase 02 monitoring started

- **Phase:** 02 — Cream launch / 04 — Redesign
- **Status:** Production live; receipt verification and 14-day monitoring in progress
- **Summary:** The owner built and deployed release head `ea92ab1`; the redesigned five-product catalog is live at `https://skinetics.ru` and the Phase 02 monitoring window runs through 2026-09-07.
- **Evidence:** HTTP 200 for all 12 intended HTML routes and `/sitemap.xml`; HTTP 404 for `/brands`, `/concerns`, and `/expert`; browser checks of the live homepage, listings, five product pages, About, Contacts, `/ingredients`, optimized images, empty-form validation, and representative serum/cream marketplace destinations.
- **Decisions:** Treat deployment as complete while keeping controlled form delivery, analytics-dashboard receipt, and server-log review explicitly open; do not open Phase 05 publication gates from deployment alone.
- **Blockers:** No rollback signal found. Reliable production event receipt and the 14-day baseline remain prerequisites for Phase 05 execution.
- **Next:** Confirm successful form delivery and analytics receipt, monitor indexation and marketplace clicks through 2026-09-07, then close Phase 02 and prepare Phase 05.

## 2026-08-24 — Phase 04 implementation validated

- **Phase:** 04 — Redesign
- **Status:** Implementation validated; deployment pending
- **Summary:** Completed the approved navigational-editorial redesign for every current route, refreshed the three serum presentation images from verified Wildberries final-gallery sources, hardened forms and analytics, and documented evidence-gated future templates without publishing them.
- **Evidence:** Phase 04 commits `f8ef714` through release head `ea92ab1`, including post-validation updates `034cc8e` and `ea92ab1`; 52 passing tests; production build with 21 generated pages; `npm run validate:phase04` across 12 current and 3 gated routes; 24 route/viewport browser checks; [validation](./phase-04-redesign/VALIDATION.md), [browser captures](./phase-04-redesign/artifacts/captures/README.md), [performance summary](./phase-04-redesign/artifacts/performance-summary.md), [responsive matrix](./phase-04-redesign/artifacts/responsive-matrix.md), [serum provenance](./phase-04-redesign/artifacts/serum-image-sources-2026-08-23.md), and [release notes](./phase-04-redesign/artifacts/release-and-rollback-notes.md).
- **Decisions:** Queue analytics immediately but load external libraries after initial rendering; preserve all URLs and videos; keep `/ingredients` noindex and all future discovery roots gated; require explicit production authorization.
- **Blockers:** No local implementation blocker. Official identity/documentary assets and meaningful Ozon history remain non-blocking future inputs. Production deployment remains pending authorization.
- **Next:** Build and deploy the Linux/amd64 artifact only after explicit authorization, then execute route, form, image, and marketplace analytics smoke tests.

## 2026-08-23 — Phase 04 implementation plan prepared

- **Phase:** 04 — Redesign
- **Status:** In progress
- **Summary:** The owner approved the written navigational-editorial design, and a test-first implementation plan was prepared for the local redesign and coordinated validation.
- **Evidence:** `docs/refactoring/phase-04-redesign/DESIGN.md` and `docs/superpowers/plans/2026-08-23-skinetics-phase-04-redesign.md`.
- **Decisions:** Preserve all existing URLs and analytics contracts; retain every file under `public/video/` while removing homepage video delivery; refresh serum presentation images from the verified final Wildberries gallery slides; document gated templates without publishing routes; keep production deployment separately authorized.
- **Blockers:** No implementation blocker is open. Official identity and documentary assets remain a non-blocking future backlog.
- **Next:** Choose an execution approach, implement the plan locally, and complete validation before any separate production authorization.

## 2026-08-23 — Phase 04 redesign approved

- **Phase:** 04 — Redesign
- **Status:** In progress
- **Summary:** Audited the current desktop and mobile interface, compared three visual directions, and accepted the navigational-editorial Skinetics system, reusable component boundaries, page conversion flows, WCAG/performance targets, image policy, and coordinated release strategy.
- **Evidence:** [Phase 04 design](./phase-04-redesign/DESIGN.md), [decision 0007](./decisions/0007-navigational-editorial-design-system.md), [future asset backlog](./phase-04-redesign/artifacts/future-asset-backlog.md), updated [findings](./phase-04-redesign/FINDINGS.md), and owner approvals recorded in the Phase 04 design conversation.
- **Decisions:** Use one shared Skinetics system with restrained text-backed brand accents; use currently verified trust facts now; retain every `public/video/` file but remove homepage video delivery; refresh all three serum presentation images from verified final Wildberries gallery slides; implement incrementally and release in one coordinated production change.
- **Blockers:** None for design or planning. Official identity, documentary, photography, and specialist assets remain a non-blocking intake backlog; production deployment remains separately authorized.
- **Next:** Owner reviews the written design, then create the detailed implementation plan.

## 2026-08-23 — Phase 03 site architecture completed

- **Phase:** 03 — Site architecture and content
- **Status:** Complete
- **Summary:** Accepted the evidence-gated dual taxonomy, preserved all current URLs, and completed the navigation, internal-linking, content, indexation, migration, and Phase 04 template requirements.
- **Evidence:** [Marketplace themes](./phase-03-site-architecture/artifacts/marketplace-question-themes.md), [content inventory and journeys](./phase-03-site-architecture/artifacts/content-inventory-and-journeys.md), [site tree and URL map](./phase-03-site-architecture/artifacts/site-tree-and-url-map.md), [navigation and internal linking](./phase-03-site-architecture/artifacts/navigation-and-internal-linking.md), [content map and page requirements](./phase-03-site-architecture/artifacts/content-map-and-page-requirements.md), [redirect matrix](./phase-03-site-architecture/artifacts/redirect-matrix.md), [decision 0006](./decisions/0006-evidence-gated-site-architecture.md), [findings](./phase-03-site-architecture/FINDINGS.md), and [validation](./phase-03-site-architecture/VALIDATION.md).
- **Decisions:** Product type remains primary; brand, concern, ingredient, and expert content are evidence-gated secondary discovery relationships; no current redirect is required.
- **Blockers:** Concern, ingredient, and expert pages remain gated; Phase 02 deployment remains pending; numerical organic demand is unavailable.
- **Next:** Begin Phase 04 design only when explicitly authorized, or complete the separately authorized Phase 02 deployment path.

## 2026-08-23 — Phase 02 cream launch implementation validated

- **Phase:** 02 — Cream launch
- **Status:** Implementation validated; deployment pending
- **Summary:** Added the Neon Beard Ultra Lift and SkineticsLab ReneWal cream records, local product imagery, the `/cream` listing, neutral five-product catalog copy, category-aware breadcrumbs, metadata, sitemap entries, and two-marketplace conversion paths.
- **Evidence:** `constants.ts`, product and listing routes, shared catalog components, `public/items/`, implementation commits `7e4cdf5`, `470ceb9`, `458e13a`, `ad5b74b`, `e046439`, and `docs/refactoring/phase-02-cream-launch/VALIDATION.md`.
- **Decisions:** Use packaging quantities 100 г and 50 г; preserve `/serum` and existing serum URLs; order Wildberries before Ozon; emit `BreadcrumbList` but defer product rich-result markup; use the owner-selected last-gallery images while treating ReneWal's printed English phrase only as package artwork; keep production deployment separately authorized.
- **Blockers:** Local implementation is ready. Production deployment and the 14-day post-launch monitoring window remain pending.
- **Next:** Build the approved Linux release artifact and deploy only after explicit authorization.

## 2026-08-23 — Phase 02 design handoff saved

- **Phase:** 02 — Cream launch
- **Status:** In progress
- **Summary:** Saved a self-contained handoff after reviewing the live marketplace cards and accepting the cream URLs and neutral five-product homepage direction.
- **Evidence:** `docs/refactoring/phase-02-cream-launch/HANDOFF.md` and `docs/refactoring/phase-02-cream-launch/artifacts/live-marketplace-review-2026-08-23.md`.
- **Decisions:** Use `/catalog/ultra-lift` and `/catalog/renewal`; show all five products on the homepage with neutral Skinetics copy; preserve `/serum` as the Dr. Health-only listing.
- **Blockers:** No external publication blocker is open. The structured-data approach and complete Phase 02 design still require approval before implementation.
- **Next:** In a fresh task, read the handoff, decide structured data, finish the architectural design, write and approve `DESIGN.md`, then create the implementation plan.

## 2026-08-23 — Phase 02 cream wording approved

- **Phase:** 02 — Cream launch
- **Status:** In progress
- **Summary:** The product owner approved the exact application and precaution wording separately for Neon Beard Ultra Lift and SkineticsLab ReneWal.
- **Evidence:** `docs/refactoring/phase-02-cream-launch/artifacts/proposed-application-and-precautions.md` and the user's written approval on 2026-08-23.
- **Decisions:** The same neutral application and precaution wording is accepted for both products; later packaging or manufacturer conflicts must supersede it.
- **Blockers:** The wording blocker is resolved. Image, INCI, claims, page-design, implementation, and launch validation work remains.
- **Next:** Complete the remaining product-evidence review and present the Phase 02 page/content design for approval.

## 2026-08-23 — Phase 02 review-only safety copy proposed

- **Phase:** 02 — Cream launch
- **Status:** Blocked
- **Summary:** Prepared one neutral application and precaution proposal for each cream after confirming that the existing serum wording contains scalp-specific guidance and should not be copied verbatim.
- **Evidence:** `docs/refactoring/phase-02-cream-launch/artifacts/proposed-application-and-precautions.md`, updated Phase 02 inputs, checklist, findings, and root status.
- **Decisions:** The draft remains non-authoritative; approval is required separately for Ultra Lift and ReneWal; no unsupported storage, age, patch-test, pregnancy, or formula-specific instructions were added.
- **Blockers:** Neither cream may be published until its application and precautions are approved and remaining product evidence and claims checks pass.
- **Next:** Product owner or manufacturer reviews and approves or corrects the proposal product by product.

## 2026-08-23 — Phase 01 catalog foundation completed

- **Phase:** 01 — Catalog foundation
- **Status:** Complete
- **Summary:** Replaced the Wildberries-only product shape with a typed multi-brand catalog, structured reusable product content, optional ordered marketplace destinations, contextual analytics adapters, and build-time integrity checks. Migrated the three published serums without changing their URLs or accepted copy.
- **Evidence:** `types.ts`, `constants.ts`, `lib/catalog.ts`, `lib/catalogIntegrity.ts`, `lib/marketplaceUrl.ts`, generic marketplace and product components, and `docs/refactoring/phase-01-catalog-foundation/VALIDATION.md`.
- **Decisions:** One primary category per product; missing marketplace links are omitted; marketplace order is global; only published complete records feed public routes; Yandex receives one compatibility goal per click.
- **Blockers:** Phase 02 cannot publish either cream until authoritative application and precaution wording is supplied and approved.
- **Next:** Obtain the missing cream wording, then review and approve the Phase 02 page/content design.

## 2026-08-22 — Phase 00 baseline completed

- **Phase:** 00 — Baseline and product truth
- **Status:** Complete
- **Summary:** Resolved the portfolio brand model and five-product scope; verified marketplace identities, volumes, barcodes, images, and available compositions; audited local routes, analytics code paths, and claims; recorded the no-traffic site baseline and a sanitized 90-day Wildberries funnel.
- **Evidence:** `docs/refactoring/phase-00-baseline/`, `docs/refactoring/shared/`, and decisions `0001` through `0005`.
- **Decisions:** Skinetics is the umbrella catalog; products belong to Dr. Health, SkineticsLab, or Neon Beard; ReneWal and Ultra Lift are product names; current URLs are preserved; Phase 01 uses the accepted marketplace-click contract.
- **Blockers:** Cream application and precaution wording must be supplied before Phase 02 publication. Official logos and brand guidelines remain a Phase 04 input. Ozon history is too recent for a baseline.
- **Next:** Start the Phase 01 catalog-foundation design in a new task.

## 2026-08-22 — Refactoring workspace initialized

- **Phase:** Program setup
- **Status:** Complete
- **Summary:** Created the six-phase documentation structure, recorded the approved roadmap, initialized shared reference files, and marked Phase 00 as ready.
- **Evidence:** `docs/refactoring/`
- **Decisions:** Use one master log, a root status dashboard, per-phase checklists, and separate decision records for durable choices.
- **Blockers:** The canonical public brand for product `771142529` remains unresolved.
- **Next:** Begin Phase 00 by confirming cream brand assignments and collecting baseline inputs.
